For the year ending 2025-12-31, QXO-PB had -$2,706,600,000 decrease in cash & cash equivalents over the period. $183,200,000 in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total net sales | 6,842,200,000 | 56,873,000 | - | - |
| Cost of products sold | 5,269,500,000 | - | - | - |
| Selling, general administrative expenses | 1,250,300,000 | - | - | - |
| Purchased software and services | - | 20,894,000 | - | - |
| Employee compensation and benefits | - | 46,984,000 | - | - |
| Stock-based compensation | 144,500,000 | 34,513,000 | - | - |
| Professional fees | - | 18,572,000 | - | - |
| General and administrative expenses | - | 5,788,000 | - | - |
| Other segment items | 457,300,000 | -97,847,000 | - | - |
| Net loss | - | - | -1,070,095 | -282,219 |
| Net (loss) income | -279,400,000 | 27,969,000 | - | - |
| Deferred income taxes | - | -1,159,000 | 337,837 | 115,107 |
| Depreciation and amortization | - | - | 328,894 | 386,847 |
| Depreciation | 108,400,000 | 247,000 | - | - |
| Amortization | 314,700,000 | 875,000 | 671,504 | 732,552 |
| Stock-based compensation | 144,500,000 | 34,513,000 | - | - |
| Amortization of debt issuance costs | 6,700,000 | - | - | - |
| Amortization of right of use assets | - | - | 126,337 | 636,428 |
| Loss on debt extinguishment | -49,700,000 | - | - | - |
| Provision for credit losses | 13,800,000 | 50,000 | 19,901 | 160,000 |
| Share-based compensation | - | - | 41,497 | 180,260 |
| Gain on sale of product line | - | - | - | 0 |
| Non-cash lease expense | 88,000,000 | 263,000 | - | - |
| Gain on bargain purchase | - | - | - | 0 |
| Deferred income taxes | -60,600,000 | - | - | - |
| Accounts receivable | -159,800,000 | -183,000 | 755,816 | 466,101 |
| Inventories | -287,800,000 | - | - | - |
| Unbilled services | - | - | -172,758 | 82,947 |
| Vendor rebates receivable | 186,800,000 | - | - | - |
| Deferred charges | - | - | -780,987 | 1,219,295 |
| Income tax receivable | 11,000,000 | - | - | - |
| Prepaid expenses and other current assets | -19,900,000 | 12,155,000 | 180,234 | 316,130 |
| Deposits and other assets | - | - | -16,105 | - |
| Other assets | - | 21,000 | - | -3,252 |
| Accounts payable | - | 1,631,000 | 1,290,693 | 1,234,530 |
| Accrued expenses | - | 33,011,000 | 222,217 | 689,555 |
| Income tax payable | - | - | 0 | -69,614 |
| Accrued interest | - | - | 750 | -5,027 |
| Deferred revenue | - | -261,000 | -617,519 | 1,207,836 |
| Accounts payable and accrued expenses | -326,400,000 | - | - | - |
| Operating lease obligations | - | - | - | 636,428 |
| Operating lease liabilities | - | -263,000 | -126,337 | - |
| Other assets and liabilities | 67,700,000 | - | - | - |
| Net cash provided by operating activities | 261,400,000 | 84,883,000 | 583,805 | 2,038,392 |
| Purchase of property and equipment | - | 102,000 | 120,927 | 38,742 |
| Acquisition of assets | - | - | 278,489 | 0 |
| Capital expenditures | 78,200,000 | - | - | 150,000 |
| Acquisition of business, net of cash acquired | 10,556,500,000 | - | - | - |
| Proceeds from sale of product line | - | - | - | 0 |
| Acquisition of assets | - | 0 | - | - |
| Other | -4,400,000 | - | - | - |
| Net cash used in investing activities | -10,630,300,000 | -102,000 | -399,416 | -188,742 |
| Borrowings under revolving lines of credit | 841,900,000 | - | - | - |
| Payments under revolving lines of credit | 842,000,000 | - | - | - |
| Borrowings under term loan | 2,250,000,000 | - | - | - |
| Payments under term loan | 1,400,000,000 | - | - | - |
| Borrowings under senior notes | 2,250,000,000 | - | - | - |
| Payment of debt issuance costs | 114,500,000 | - | - | - |
| Payment of other debt | 0 | - | - | - |
| Payments under equipment financing facilities and finance leases | 30,300,000 | - | - | - |
| Proceeds from issuance of common stock related to equity awards | 18,900,000 | - | - | - |
| Proceeds from issuance of common stock, net of issuance costs | 4,256,000,000 | - | - | - |
| Proceeds from issuance of mandatory convertible preferred stock, net of issuance costs | 558,100,000 | - | - | - |
| Proceeds from issuance of convertible preferred stock and warrants, net of issuance costs | 0 | 981,538,000 | - | - |
| Proceeds from the issuance of common stock and pre-funded warrants, net of issuance costs | 0 | 4,051,103,000 | - | - |
| Payment of cash dividend | - | - | 1,051,256 | 0 |
| Payment of taxes related to net share settlement of equity awards | 20,500,000 | - | - | - |
| Proceeds from issuance of stock, net of expenses | - | - | - | 0 |
| Payment of common-stock dividend | 0 | 17,400,000 | - | - |
| Payment of long-term debt | - | 1,696,000 | 680,145 | 316,138 |
| Payment of long-term debt related party | - | - | 103,333 | 108,309 |
| Payment of long-term convertible debt related party | - | - | - | 0 |
| Payment for fractional shares | - | 45,000 | - | - |
| Payment of dividends on convertible preferred stock | 90,000,000 | 32,250,000 | - | - |
| Payment of finance lease obligations | - | 170,000 | 214,990 | 230,687 |
| Payment of dividends on mandatory convertible preferred stock | 14,800,000 | - | - | - |
| Net cash provided by financing activities | 7,662,800,000 | 4,981,080,000 | -2,049,724 | -655,134 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -500,000 | - | - | - |
| Net increase (decrease) in cash, cash equivalents and restricted cash | - | 5,065,861,000 | -1,865,335 | 1,194,516 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -2,706,600,000 | - | - | - |
| Cash, cash equivalents and restricted cash, beginning of period | 5,072,000,000 | 6,143,000 | 8,008,633 | 6,814,117 |
| Cash, cash equivalents and restricted cash, end of period | 2,365,400,000 | 5,072,004,000 | 6,143,298 | 8,008,633 |
QXO, Inc. (QXO-PB)
QXO, Inc. (QXO-PB)